Advanced Research in Thyroid and Parathyroid Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 216
Special Issue Editor
Interests: anaplastic thyroid cancer; targeted therapy strategies; integrated immunotherapy; tumor microenvironment
Special Issue Information
Dear Colleagues,
Thyroid and parathyroid diseases encompass a wide spectrum of conditions, ranging from benign disorders to aggressive malignancies. Thyroid cancer remains one of the most prevalent endocrine malignancies, with its incidence continuing to rise globally. While differentiated thyroid cancer (DTC) generally has a favorable prognosis when conventional treatments such as surgery, radioactive iodine (RAI) therapy, and thyroid hormone suppression are implemented, the management of aggressive subtypes—including poorly differentiated thyroid carcinoma (PDTC), anaplastic thyroid carcinoma (ATC), and medullary thyroid carcinoma (MTC)—remains a significant clinical challenge. Additionally, disorders of the parathyroid glands, particularly primary hyperparathyroidism and parathyroid carcinoma, present unique diagnostic and therapeutic challenges that warrant further investigation.
Recent advances in molecular profiling have provided deeper insights into the genetic and epigenetic alterations that promote the progression of tumors, providing a basis for novel targeted therapies and immunotherapy approaches. Furthermore, the role of calcium metabolism, parathyroid hormone regulation, and their systemic involvement in endocrine health have attracted the attention of researchers.
This Special Issue aims to highlight innovative developments in the diagnosis and treatment of thyroid and parathyroid diseases. We welcome contributions that explore innovative therapeutic strategies, precision medicine applications, and the role of tumor microenvironment modulation in disease progression. The scope of this Special Issue includes emerging biomarkers for prognosis and treatment selection, the mechanisms of treatment resistance, advances in systemic therapies, and novel surgical and radiotherapeutic techniques. We particularly welcome the submission of studies that connect laboratory discoveries with clinical applications, offering new perspectives regarding the evolving landscape of thyroid and parathyroid disease management. Through this collection, we seek to provide a comprehensive and up-to-date resource that informs future research and clinical practice.
Dr. Anping Su
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thyroid cancer treatment
- tumor microenvironment
- immunotherapy
- targeted therapy
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
